Provided herein is a prodrug platform useful to deliver pharmaceutically active amines, amides and phenols and their use in the diagnosis, prevention and/or treatment of various diseases. Compared with the parent drug (e.g., Gemcitabine), the prodrugs show a significant overall safety improvement (therapeutic index (TI) improvement), especially in liver.
本文提供了一种用于传递药用活性胺、酰胺和
酚的前药平台,以及它们在诊断、预防和/或治疗各种疾病中的用途。与母药(例如
吉西他滨)相比,前药在整体安全性方面表现出明显改善(疗效指数(TI)改善),尤其是在肝脏方面。